Back
Cytokinetics 10K Form
Sell
49
CYTK
Cytokinetics
Last Price:
55.63
Seasonality Move:
12.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | CYTK/Cytokinetics Quarterly |
| 2023-11-03 | 10Q | CYTK/Cytokinetics Quarterly |
| 2023-08-03 | 10Q | CYTK/Cytokinetics Quarterly |
| 2023-05-05 | 10Q | CYTK/Cytokinetics Quarterly |
| 2022-11-04 | 10Q | CYTK/Cytokinetics Quarterly |
| 2022-08-05 | 10Q | CYTK/Cytokinetics Quarterly |
Receive CYTK News And Ratings
See the #1 stock for the next 7 days that we like better than CYTK
CYTK Financial Statistics
Sales & Book Value
| Annual Sales: | $7.53M |
|---|---|
| Cash Flow: | $-101.23M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.92 |
| Price / Book: | 56.93 |
Profitability
| EPS (TTM): | -5.37000 |
|---|---|
| Net Income (TTM): | $-545.28M |
| Gross Margin: | $-322.59M |
| Return on Equity: | 0% |
| Return on Assets: | -58.3% |
Cytokinetics Earnings Forecast
Key Cytokinetics Financial Ratios
- The Gross Profit Margin over the past 18 years for CYTK is -4,284.10%.
- The Selling, General & Administrative Expenses for CYTK have been equal to 2,305.60% of Gross Profit Margin.
- The Research & Development expenses have been 227.10% of Revenue.
- The Interest Expense is -10.96% of Operating Income.
- The Net Earning history of CYTK is -6,988.63% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 12 years.
Cytokinetics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYTK |
| CUSIP: | 23282W |
| Website: | cytokinetics.com |
Debt
| Debt-to-Equity Ratio: | 6.03 |
|---|---|
| Current Ratio: | 10.39 |
| Quick Ratio: | 10.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CYTK Technical Analysis vs Fundamental Analysis
Sell
49
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a Sell
The current Cytokinetics [CYTK] share price is $52.52. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.